The Ecstasy and Related Drugs Reporting System (EDRS) is a national monitoring system for ecstasy and related drugs that is intended to serve as a strategic early warning system, identifying emerging trends of local and national interest in the markets for these drugs. The EDRS was conducted across Australia for the first time in 2003.
The EDRS is based on the Illicit Drug Reporting System (IDRS) methodology and consists of three components: interviews with regular ecstasy users (REU) and Regular Psychostimulant Users (RPU); interviews with key experts (KEs), professionals who have regular contact with regular psychostimulant users through their work; and analysis and examination of indicator data sources related to ecstasy and other related drugs. The EDRS monitors the price, purity, availability and patterns of use of ecstasy, methamphetamine, cocaine, ketamine, GHB, MDA and LSD. The EDRS is designed to be sensitive to trends, providing data in a timely manner, rather than describing issues in extensive detail.
It is important to note that the results from the user surveys are not representative of ecstasy and other related drug use in the general population, but this is not the aim of these data. These data are intended to provide evidence that is indicative of emerging issues that warrant further investigation. Participants are a sentinel group of regular ecstasy/psychostimulant users that provide information on patterns of drug use and market trends.
This handout (provided as part of the 2014 National Drug Trends Conference) presents key findings for the 2014 EDRS (survey component) and may be subject to minor change. Final figures will appear in the 2014 national and jurisdictional reports, to be released next year (April 2015). Previous years’ data are available in reports published elsewhere, and are accessible on the NDARC website.